Elena Gabriela Chiorean

15PUBLICATIONS
88CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersPacific Peoples theory of change models for health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Feb 13, 2026
Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Metastatic Pancreatic Ductal Adenocarcinoma: PCRT16-001.

Elena Gabriela Chiorean, Sheela R Damle, David B Zhen

|Dec 15, 2025
Rechallenge With an Epidermal Growth Factor Receptor Inhibitor in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.

Amy H Huang, Gin Yi Lee, Chuan Angel Lu

|Jul 09, 2025
LODESTAR: A Single-Arm Phase II Study of Rucaparib in Solid Tumors With Pathogenic Germline or Somatic Variants in Homologous Recombination Repair Genes.

Sriram Anbil, Nicholas J Seewald, E Gabriela Chiorean

|Jun 13, 2025
Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers.

Gentry G King, Kelsey K Baker, Andrew L Coveler

|Jan 06, 2025
Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With RAS/BRAF Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial.

Kanwal Pratap Singh Raghav, Katherine A Guthrie, Benjamin Tan

|Dec 16, 2024
HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma.

Naomi Yamamoto, Stephanie Dobersch, Ian Loveless

Pageof 3

Frequent Collaborators

4 joint publications

Rachael A Safyan

3 joint publications

David B Zhen

3 joint publications

Andrew L Coveler

3 joint publications

Howard S Hochster